KevinMD November 30, 2024
We dive into the evolving landscape of treatment for restless legs syndrome (RLS) with neurologist Andrew Spector. For decades, patients have been prescribed dopamine agonists like ropinirole and pramipexole, often unaware that these medications could worsen their symptoms over time. Andrew discusses the new clinical practice guidelines from the American Academy of Sleep Medicine, which mark a significant shift in RLS treatment and offer hope for better alternatives. Learn about the risks of long-term dopamine agonist use, patient experiences, and promising new therapies.
Andrew Spector is a neurologist.
He discusses the KevinMD article, “The unexpected truth about restless legs syndrome treatments.”
Transcript
Kevin Pho: Hi, and welcome to the show. Subscribe at KevinMD.com/podcast. Today, we welcome back Andrew Spector. He’s...
Today's Sponsors
Today's Sponsor